AB-Fubinaca N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide.

$460.32$910.21

AB-FUBINACA is a synthetic cannabinoid that acts as a potent agonist for the cannabinoid receptors CB1 and CB2. It was originally developed by Pfizer in 2009 as an analgesic medication, but it was never tested on humans and was subsequently discovered in synthetic cannabis products, leading to its classification as a designer drug.

As a synthetic cannabinoid, AB-FUBINACA can induce effects similar to THC (tetrahydrocannabinol), the active compound in cannabis, but often with much greater potency. Its use and distribution have been associated with various legal and health concerns due to its potent psychoactive effects and potential for abuse. Governments in many countries have regulated or banned its sale and use.

SKU: N/A Category:
×
New order

[variable_1] from [variable_2] just purchased [variable_3]  [variable_4] .